Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 132.13 Bn | 129.26 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 111.43 Bn | 102.21 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 68.97 Bn | 67.52 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.64 Bn | 1.29 Bn | 7.35% |
| 6 | Dexcom | 28.91 Bn | 27.79 Bn | 750.30 Mn | 14.29% |
| 7 | GE HealthCare Technologies | 28.86 Bn | 26.58 Bn | 1.98 Bn | 8.56% |
| 8 | Smith & Nephew | 28.12 Bn | 27.54 Bn | - | 7.10% |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | -8.71% |
| 10 | Standard Biotools | 302.22 Mn | -152.96 Mn | 11.31 Mn | -60.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.77% |
| Dec 31, 2025 | -15.37% |
| Sep 30, 2025 | -50.60% |
| Jun 30, 2025 | -46.73% |
| Mar 31, 2025 | -2.66% |
| Dec 31, 2024 | -5.84% |
| Sep 30, 2024 | 71.09% |
| Jun 30, 2024 | 73.60% |
| Mar 31, 2024 | 79.13% |
| Dec 31, 2023 | -5.71% |
| Sep 30, 2023 | -7.70% |
| Jun 30, 2023 | -10.09% |
| Mar 31, 2023 | -9.74% |
| Dec 31, 2022 | -8.50% |
| Sep 30, 2022 | -8.06% |
| Jun 30, 2022 | -1.60% |
| Mar 31, 2022 | 16.46% |
| Dec 31, 2021 | 59.91% |
| Sep 30, 2021 | 283.92% |
| Jun 30, 2021 | 252.42% |